Skip to main content
. 2022 Aug 5;13:20406223221109655. doi: 10.1177/20406223221109655

Table 1.

Clinical characteristics on admission to the weaning center – comparison of patients with unsuccessful and successful decannulation.

Clinical characteristics All patients (n = 532) Decannulation failure (n = 216) Decannulation success (n = 316) p value a
Age (years) 70 (62–77) 73 (66–78) 68 (60–75) <0.01 b
Male gender 332 (62.4) 137 (63.4) 195 (61.7) 0.688 c
Body mass index (kg/m2) 27.3 (± 6.6) 26.3 (± 5.8) 27.9 (± 7.1) <0.01 b
 Obesity (defined as BMI ⩾30 kg/m2) 142 (26.7) 51 (23.6) 91 (28.8) 0.057 c
Smoking history 243 (45.7) 94 (43.5) 149 (47.2) 0.409 c
APACHE-II (points) 17 (13–20) 17 (14–20) 16 (13–19) <0.01 b
Albumin (g/dl) 2.2 (± 0.6) 2.1 (± 0.6) 2.2 (± 0.5) <0.01 b
Pre-existing domiciliary NIV 32 (6.0) 19 (8.8) 13 (4.1) 0.026 c
Ventilator days on admission 22 (15–33) 21 (14–33) 23 (16–33) 0.227 b
Intubation to tracheostomy (days) 10 (6–14) 9 (6–14) 10 (7–15) 0.119 b
Percutaneous tracheostomy 391 (73.5) 150 (69.4) 241 (76.3) 0.080 c
ECLA 35 (6.6) 7 (3.2) 28 (8.9) 0.010 c
Reason for mechanical ventilation
 Pneumonia 182 (34.2) 71 (32.9) 111 (35.1) 0.591 c
 Surgery 122 (22.9) 48 (22.2) 74 (23.4) 0.748 c
 Acute exacerbation of COPD 57 (10.7) 26 (12.0) 31 (9.8) 0.415 c
 Sepsis (including septic shock) 53 (10.0) 21 (9.7) 32 (10.1) 0.879 c
 Cardiopulmonary resuscitation 37 (7.0) 13 (6.0) 24 (7.6) 0.483 c
 Acute heart failure 18 (3.4) 10 (4.6) 8 (2.5) 0.189 c
 Other 63 (11.8) 27 (12.5) 36 (11.4) 0.698 c
Comorbidities
 Charlson comorbidity index (points) 6 (4–7) 6 (5–8) 5 (4–7) <0.01 b
 Diabetes mellitus 161 (30.3) 64 (29.6) 97 (30.7) 0.793 c
 Coronary artery disease 151 (28.4) 60 (27.8) 91 (28.8) 0.798 c
 Renal insufficiency 147 (27.6) 62 (28.7) 85 (26.9) 0.648 c
  Hemodialysis on admission 71 (13.3) 32 (14.8) 39 (12.3) 0.320 c
 COPD 140 (26.3) 58 (26.9) 82 (25.9) 0.817 c
 Immunosuppression 86 (16.2) 26 (12.0) 60 (19.0) 0.033 c
 Chronic heart failure 84 (15.8) 33 (15.3) 51 (16.1) 0.789 c
 Malignancy 51 (9.6) 19 (8.8) 32 (10.1) 0.609 c
 Hepatopathy 35 (6.6) 13 (6.0) 22 (7.0) 0.667 c
 Interstitial lung diseases 32 (6.0) 8 (3.7) 24 (7.6) 0.064 c
 Neuromuscular diseases 19 (3.6) 15 (6.9) 4 (1.3) <0.01 c
 Pre-existing dysphagia 13 (2.4) 11 (5.1) 2 (0.6) <0.01 c

APACHE-II, Acute Physiology and Chronic Health Evaluation II score; BMI, body mass index; COPD, chronic obstructive pulmonary disease; ECLA, extracorporeal lung assistance; NIV, non-invasive ventilation.

Continuous variables are presented as median (– interquartile range [IQR]) or arithmetic means (± standard deviation); categorical variables are presented as numbers (%).

a

p value for differences between patients with unsuccessful and successful decannulation. Significant values are in bold.

b

Mann–Whitney U-test.

c

Chi-square test.